Tag: Health Solutions

GKSD’s Kamel Ghribi Reaffirms Commitment to Syria's Reconstruction during Strategic Visit Sticky Post
Europe, Middle East

GKSD’s Kamel Ghribi Reaffirms Commitment to Syria’s Reconstruction during Strategic Visit

Milan, Italy– Friday, May 2nd 2025 – Kamel Ghribi, the President of GKSD Group, has reaffirmed his company’s commitment to supporting ongoing reconstruction efforts in Syria. He stated this during a strategic visit to the Syrian capital, Damascus, earlier this week. During the visit, Mr Ghribi held high-level meetings with senior Syrian government officials, including the President H.E. Ahmed Al Sharaa, to discuss avenues for … Continue reading GKSD’s Kamel Ghribi Reaffirms Commitment to Syria’s Reconstruction during Strategic Visit

Impact Newswire
GKSD
Europe

GKSD Announces Landmark Agreement with Albania to Enhance Healthcare and Education

Rome, Italy – Wednesday, April 30th, 2025 – GKSD Holding, a leading global organization, today announced a significant Memorandum of Understanding (MoU) signed with the Albanian government to bolster healthcare and education in Albania.  The agreement, signed by GKSD Chairman Kamel Ghribi and GSD Vice President Paolo Rotelli, alongside Albanian Prime Minister H.E. Edi Rama, the Italian Ambassador, and the Albanian Minister of Health, marks … Continue reading GKSD Announces Landmark Agreement with Albania to Enhance Healthcare and Education

Impact Newswire
Olympus Appoints New CEO -  Bob White
Asia

Olympus Appoints New CEO –  Bob White

Names Bob White Representative Executive Officer, President, Chief Executive Officer and a new Director candidate News Release – TOKYO, April 25, 2025 – Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer and more fulfilling, today announces appointment of a Chief Executive Officer (CEO) aimed at accelerating its ongoing transformation efforts in the medtech space. The Board of Directors has … Continue reading Olympus Appoints New CEO –  Bob White

Impact Newswire
New Guideline Aims to Transform Obesity Care for Children and Adolescents
Global

New Guideline Aims to Transform Obesity Care for Children and Adolescents

First Canadian update in nearly 20 years prioritizes improvements in health and quality of life over weight loss outcomes.  Press Release – April 14, 2025 – EDMONTON, AB – Healthcare providers and families have a new roadmap to support collaborative, fully-informed, evidence-based care for children and adolescents living with obesity, thanks to a new clinical practice guideline published today in the Canadian Medical Association Journal.  The … Continue reading New Guideline Aims to Transform Obesity Care for Children and Adolescents

Impact Newswire
Yisak Birhanu Bule Became an AI Expert Against All Odds
Africa

From Rural Ethiopia to Zindi Data Science Champion: How Yisak Birhanu Bule Became an AI Expert Against All Odds

In the quiet village of Lisana, Ethiopia, where electric light was a rare luxury and internet access a futuristic dream in early 2000s, a young boy was assembling toy cars and tinkering with rudimentary electrical circuits. That boy, now 24-year-old Yisak Birhanu Bule, would grow up to become one of Africa’s rising stars in data science – using artificial intelligence to tackle some of the … Continue reading From Rural Ethiopia to Zindi Data Science Champion: How Yisak Birhanu Bule Became an AI Expert Against All Odds

Faustine Ngila
Freed's co-founder & CEO Erez Druk and his physician-wife, Gabi Meckler. (Photo: Business Wire)
United States

Freed Secures $30M Series A Led by Sequoia Capital to Free Clinicians from Administrative Burdens with AI Assistant

This latest round of funding fuels Freed’s rapid expansion beyond AI note writing, building a next-generation AI clinician assistant as the company surpasses 17,000 paying clinicians Press Release – March 05, 2025 – SAN FRANCISCO – Freed, an AI clinician assistant designed to reduce the burdens of medical documentation, today announced it has raised $30 million in Series A funding, led by Sequoia Capital with … Continue reading Freed Secures $30M Series A Led by Sequoia Capital to Free Clinicians from Administrative Burdens with AI Assistant

Impact Newswire
Philips advances imaging innovation with remote scanning capabilities across Europe
Europe

Philips advances imaging innovation with remote scanning capabilities across Europe

News Release – Feb 25, 2025 Vendor-agnostic, multi-modality Radiology Operations Command Center connects technologists, radiologists, and imaging experts in real time EU Medical Device Regulation certified remote scanning capability helps to improve the operation of radiology workflows Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Philips Radiology Operations Command Center Console has received its EU Medical Device Regulation … Continue reading Philips advances imaging innovation with remote scanning capabilities across Europe

Impact Newswire
Kamel Ghribi
Global

Kamel Ghribi Impact Pioneer in Health Innovation & Infrastructure

Distinguished entrepreneur and visionary, Kamel Ghribi, has significantly transformed healthcare delivery across the Middle East through his pioneering smart clinics. As the Chairman of GKSD Healthcare, Ghribi has seamlessly integrated innovative healthcare solutions with sustainable practices, setting a new benchmark in the region. The Success of Smart Clinics in the Middle East Under Ghribi’s leadership, GKSD Healthcare has expanded its footprint across the Middle East … Continue reading Kamel Ghribi Impact Pioneer in Health Innovation & Infrastructure

Impact Newswire
JOHNSON & JOHNSON
United States

Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.

Acquisition includes CAPLYTA® (lumateperone), the first and only U.S. FDA-approved treatment for bipolar I and II depression as an adjunctive and monotherapy; also approved for the treatment of schizophrenia in adults sNDA submitted to U.S. FDA for CAPLYTA® as adjunctive treatment for major depressive disorder; if approved, CAPLYTA® has potential to become a standard of care for most common depressive disorders CAPLYTA® adds to Johnson & Johnson’s robust lineup of … Continue reading Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.

Impact Newswire